Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) closed at $213.49 in the last session, up 0.68% from day before closing price of $212.04. In other words, the price has increased by $0.68 from its previous closing price. On the day, 0.73 million shares were traded. MDGL stock price reached its highest trading level at $217.14 during the session, while it also had its lowest trading level at $197.86.
Ratios:
We take a closer look at MDGL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.38 and its Current Ratio is at 5.38. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on April 22, 2024, initiated with a Underperform rating and assigned the stock a target price of $150.
On March 15, 2024, B. Riley Securities Upgraded its rating to Neutral which previously was Sell and also upped its target price recommendation from $155 to $270.
On March 06, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $382.Citigroup initiated its Buy rating on March 06, 2024, with a $382 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 08 ’24 when FRIEDMAN PAUL A sold 26,270 shares for $246.19 per share. The transaction valued at 6,467,491 led to the insider holds 185,735 shares of the business.
Taub Rebecca sold 2,676 shares of MDGL for $658,258 on Apr 08 ’24. The Pres., R&D, and CMO now owns 458,999 shares after completing the transaction at $245.99 per share. On Apr 05 ’24, another insider, FRIEDMAN PAUL A, who serves as the Director of the company, sold 27,613 shares for $243.40 each. As a result, the insider received 6,721,081 and left with 185,735 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDGL now has a Market Capitalization of 4477227008 and an Enterprise Value of 3730963200.
Stock Price History:
The Beta on a monthly basis for MDGL is -0.34, which has changed by -0.27818912 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, MDGL has reached a high of $322.67, while it has fallen to a 52-week low of $119.76. The 50-Day Moving Average of the stock is -11.75%, while the 200-Day Moving Average is calculated to be 5.72%.
Shares Statistics:
According to the various share statistics, MDGL traded on average about 576.52K shares per day over the past 3-months and 350220 shares per day over the past 10 days. A total of 19.88M shares are outstanding, with a floating share count of 17.08M. Insiders hold about 18.63% of the company’s shares, while institutions hold 89.28% stake in the company. Shares short for MDGL as of 1711584000 were 3362431 with a Short Ratio of 5.83, compared to 1709164800 on 3464813. Therefore, it implies a Short% of Shares Outstanding of 3362431 and a Short% of Float of 19.42.
